Year-End Termination

ML STRATEGIES, LLC for MGI PHARMA INC

Firm
Client
Income
$40,000
Expenses
—
Terminated
Nov 1, 2007

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
Year-End Termination Amendment Dec 5, 2007 $40,000 Replaced
Year-End Termination (this page) Mar 9, 2009 $40,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

S. 1082 FDA Revitalization Act

LobbyistCovered position, as disclosed
MARK BUSE —
KENNETH CONNOLLY New Staff Director Senate EPW Committee
STEVEN IRIZARRY —
DAVID LEITER —
PATRICK D MARA —
ROBERT NEAL MARTIN —
JEREMY RABINOVITZ New Chief of Staff - Congresswoman Lois Capps

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1082 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.